Antibodies against interleukin-1 receptor and uses thereof
This invention relates to an antibody binding to human IL-1R and inhibiting the binding of human IL-1 to IL-1R, characterized in that said antibody comprises variable heavy chain region CDR1(aa 45-54), CDR2(aa 69-84) and CDR3(aa 117-123) containing SEQ ID NO:1 of CDRs, and variable light chain regio...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | BARTKE, ILSE CARR, FRANCIS EUGUI, ELSIE M FERTIG, GEORG TRUITT, THERESA PATRICIA CHIZZONITE, RICHARD ANTHONY RUEGER, PETRA SCHUMACHER, RALF LANZENDOERFER, MARTIN HAMILTON, ANITA |
| description | This invention relates to an antibody binding to human IL-1R and inhibiting the binding of human IL-1 to IL-1R, characterized in that said antibody comprises variable heavy chain region CDR1(aa 45-54), CDR2(aa 69-84) and CDR3(aa 117-123) containing SEQ ID NO:1 of CDRs, and variable light chain region CDR1 (aa 43-57), CDR2 (aa 73-79) and CDR3 (aa 112-120) containing SEQ ID NO.2, or is a chimeric, humanized or T cell epitope depleted antibody variant or a fragment of said antibody showing an IC50 value of 35 pM or lower for the inhibition of IL-1 mediated secretion of IL-8 in human fibroblast cells like MRC5 (ATCC CCL 171) has advantageous properties for the treatment of inflammatory diseases. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW200513261A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW200513261A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW200513261A3</originalsourceid><addsrcrecordid>eNrjZLByzCvJTMpPyUwtVkhMT8zMKy5RyMwrSS3KSS3NzszTNVQoSk1OLSjJL1JIzEtRKC0GqivJSC1KzU_jYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxIeFGBgamhsZGZoaOxsSoAQCEji8y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Antibodies against interleukin-1 receptor and uses thereof</title><source>esp@cenet</source><creator>BARTKE, ILSE ; CARR, FRANCIS ; EUGUI, ELSIE M ; FERTIG, GEORG ; TRUITT, THERESA PATRICIA ; CHIZZONITE, RICHARD ANTHONY ; RUEGER, PETRA ; SCHUMACHER, RALF ; LANZENDOERFER, MARTIN ; HAMILTON, ANITA</creator><creatorcontrib>BARTKE, ILSE ; CARR, FRANCIS ; EUGUI, ELSIE M ; FERTIG, GEORG ; TRUITT, THERESA PATRICIA ; CHIZZONITE, RICHARD ANTHONY ; RUEGER, PETRA ; SCHUMACHER, RALF ; LANZENDOERFER, MARTIN ; HAMILTON, ANITA</creatorcontrib><description>This invention relates to an antibody binding to human IL-1R and inhibiting the binding of human IL-1 to IL-1R, characterized in that said antibody comprises variable heavy chain region CDR1(aa 45-54), CDR2(aa 69-84) and CDR3(aa 117-123) containing SEQ ID NO:1 of CDRs, and variable light chain region CDR1 (aa 43-57), CDR2 (aa 73-79) and CDR3 (aa 112-120) containing SEQ ID NO.2, or is a chimeric, humanized or T cell epitope depleted antibody variant or a fragment of said antibody showing an IC50 value of 35 pM or lower for the inhibition of IL-1 mediated secretion of IL-8 in human fibroblast cells like MRC5 (ATCC CCL 171) has advantageous properties for the treatment of inflammatory diseases.</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; DERIVATIVES THEREOF ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; SUGARS ; VINEGAR ; WINE</subject><creationdate>2005</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050416&DB=EPODOC&CC=TW&NR=200513261A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20050416&DB=EPODOC&CC=TW&NR=200513261A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>BARTKE, ILSE</creatorcontrib><creatorcontrib>CARR, FRANCIS</creatorcontrib><creatorcontrib>EUGUI, ELSIE M</creatorcontrib><creatorcontrib>FERTIG, GEORG</creatorcontrib><creatorcontrib>TRUITT, THERESA PATRICIA</creatorcontrib><creatorcontrib>CHIZZONITE, RICHARD ANTHONY</creatorcontrib><creatorcontrib>RUEGER, PETRA</creatorcontrib><creatorcontrib>SCHUMACHER, RALF</creatorcontrib><creatorcontrib>LANZENDOERFER, MARTIN</creatorcontrib><creatorcontrib>HAMILTON, ANITA</creatorcontrib><title>Antibodies against interleukin-1 receptor and uses thereof</title><description>This invention relates to an antibody binding to human IL-1R and inhibiting the binding of human IL-1 to IL-1R, characterized in that said antibody comprises variable heavy chain region CDR1(aa 45-54), CDR2(aa 69-84) and CDR3(aa 117-123) containing SEQ ID NO:1 of CDRs, and variable light chain region CDR1 (aa 43-57), CDR2 (aa 73-79) and CDR3 (aa 112-120) containing SEQ ID NO.2, or is a chimeric, humanized or T cell epitope depleted antibody variant or a fragment of said antibody showing an IC50 value of 35 pM or lower for the inhibition of IL-1 mediated secretion of IL-8 in human fibroblast cells like MRC5 (ATCC CCL 171) has advantageous properties for the treatment of inflammatory diseases.</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>DERIVATIVES THEREOF</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>SUGARS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2005</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLByzCvJTMpPyUwtVkhMT8zMKy5RyMwrSS3KSS3NzszTNVQoSk1OLSjJL1JIzEtRKC0GqivJSC1KzU_jYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxIeFGBgamhsZGZoaOxsSoAQCEji8y</recordid><startdate>20050416</startdate><enddate>20050416</enddate><creator>BARTKE, ILSE</creator><creator>CARR, FRANCIS</creator><creator>EUGUI, ELSIE M</creator><creator>FERTIG, GEORG</creator><creator>TRUITT, THERESA PATRICIA</creator><creator>CHIZZONITE, RICHARD ANTHONY</creator><creator>RUEGER, PETRA</creator><creator>SCHUMACHER, RALF</creator><creator>LANZENDOERFER, MARTIN</creator><creator>HAMILTON, ANITA</creator><scope>EVB</scope></search><sort><creationdate>20050416</creationdate><title>Antibodies against interleukin-1 receptor and uses thereof</title><author>BARTKE, ILSE ; CARR, FRANCIS ; EUGUI, ELSIE M ; FERTIG, GEORG ; TRUITT, THERESA PATRICIA ; CHIZZONITE, RICHARD ANTHONY ; RUEGER, PETRA ; SCHUMACHER, RALF ; LANZENDOERFER, MARTIN ; HAMILTON, ANITA</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW200513261A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2005</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>DERIVATIVES THEREOF</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>SUGARS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>BARTKE, ILSE</creatorcontrib><creatorcontrib>CARR, FRANCIS</creatorcontrib><creatorcontrib>EUGUI, ELSIE M</creatorcontrib><creatorcontrib>FERTIG, GEORG</creatorcontrib><creatorcontrib>TRUITT, THERESA PATRICIA</creatorcontrib><creatorcontrib>CHIZZONITE, RICHARD ANTHONY</creatorcontrib><creatorcontrib>RUEGER, PETRA</creatorcontrib><creatorcontrib>SCHUMACHER, RALF</creatorcontrib><creatorcontrib>LANZENDOERFER, MARTIN</creatorcontrib><creatorcontrib>HAMILTON, ANITA</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>BARTKE, ILSE</au><au>CARR, FRANCIS</au><au>EUGUI, ELSIE M</au><au>FERTIG, GEORG</au><au>TRUITT, THERESA PATRICIA</au><au>CHIZZONITE, RICHARD ANTHONY</au><au>RUEGER, PETRA</au><au>SCHUMACHER, RALF</au><au>LANZENDOERFER, MARTIN</au><au>HAMILTON, ANITA</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Antibodies against interleukin-1 receptor and uses thereof</title><date>2005-04-16</date><risdate>2005</risdate><abstract>This invention relates to an antibody binding to human IL-1R and inhibiting the binding of human IL-1 to IL-1R, characterized in that said antibody comprises variable heavy chain region CDR1(aa 45-54), CDR2(aa 69-84) and CDR3(aa 117-123) containing SEQ ID NO:1 of CDRs, and variable light chain region CDR1 (aa 43-57), CDR2 (aa 73-79) and CDR3 (aa 112-120) containing SEQ ID NO.2, or is a chimeric, humanized or T cell epitope depleted antibody variant or a fragment of said antibody showing an IC50 value of 35 pM or lower for the inhibition of IL-1 mediated secretion of IL-8 in human fibroblast cells like MRC5 (ATCC CCL 171) has advantageous properties for the treatment of inflammatory diseases.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW200513261A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA DERIVATIVES THEREOF ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS SUGARS VINEGAR WINE |
| title | Antibodies against interleukin-1 receptor and uses thereof |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A48%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=BARTKE,%20ILSE&rft.date=2005-04-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW200513261A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |